Company Research Report on Kyntox Biotech
Company Overview
- Name: Kyntox Biotech Private Limited
- Mission: Kyntox Biotech is driven to overcome the hurdles in the healthcare industry, leveraging technology to save lives across all living beings—humans and animals alike.
- Founding Year: 2017
- Founders: Dr. Gopi Kadiyala (Co-Founder and CEO) and Dr. Swetha Kadiyala (Co-Founder and COO)
- Key People:
- Dr. Gopi Kadiyala - CEO
- Dr. Swetha Kadiyala - COO
- Headquarters: #336, Second Cross Road, 1st Block, Rahmath Nagar, RT Nagar, Bangaluru, Karnataka, PIN- 560032, India
- Number of Employees: No information is available
- Revenue: No information is available
- Notable Achievements: Known for its innovations in passive immunotherapy, the company focuses on treating snake bites and improving agricultural yields through products for aqua farming and shrimp culture.
Products
Snake Venom Medical Solutions
- High Level Description: Developing medical solutions using snake venom.
- Key Features: Focuses on treating snake bites effectively.
IGY Immune Science
- High Level Description: Solutions based on IGY immune technology for both humans and animals.
- Key Features: Aims to improve life quality through passive immunotherapy.
Aqua Farming Solutions
- High Level Description: Products designed to solve common issues in aqua farming.
- Key Features: Targets to improve production, lifespan, and yield.
Shrimp Culture Products
- High Level Description: A wide range of products to enhance shrimp farming.
- Key Features: Improves shrimp health and significantly boosts yield.
Diagnostic Platform
- High Level Description: A diagnostic platform for differentiating snake bites and other ailments like H. pylori, COVID, WSSV.
- Key Features: Offers specific and accurate diagnostic solutions.
Recent Developments
- New Products Launched: No information is available regarding the launch of new products.
- New Features Added: No information is available about new features added to existing products.
- Partnerships: No information is available regarding any new partnerships.
Company Presence
- Geographical Reach: Products are available across India.
- Market Penetration: The company works with more than 7,000 customers, 12+ partners across 5+ states.
Conclusion
Kyntox Biotech is highly committed to improving health outcomes through innovative biotechnology solutions. By advancing the use of snake venom and IGY immune technology, the company plays a crucial role in enhancing both human and animal health. Despite being relatively young, it demonstrates a robust portfolio aimed at overcoming entrenched challenges in healthcare and agriculture.
